Granules Pharmaceuticals Inc. Recall: Dextroamphetamine Saccharate, Amphetamine Aspartate
Granules Pharmaceuticals Inc. Recall: Dextroamphetamine Saccharate, Amphetamine Aspartate is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Granules Pharmaceuticals Inc.; Product: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine S
| Recalling firm | Granules Pharmaceuticals Inc. |
|---|---|
| Product | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 20 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-032-01 |
| Reason for recall | Failed Impurities/Degradation Specifications: |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Ongoing |
| Distribution | Distributed Nationwide in the USA |
| Recall initiated | 20250828 |
| Recall number | D-0672-2025 |
| Category | drug |
| State | VA |
| Country | United States |
$29/mo
Try RecallGuard →